Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene locus produces a long non-coding RNA (lncRNA) that is transcribed antisense to the ZNF429 gene. It does not encode a protein. Antisense transcripts can modulate the expression of their sense gene counterparts through various mechanisms such as transcriptional interference, changes to chromatin state, or RNA duplex formation. There is currently no direct evidence for a specific biological function or disease association for this transcript. Antisense lncRNAs broadly are involved in gene regulation and may be relevant to disease, but this specific transcript is not recognized as a therapeutic target.
Not applicable for drugs, but antisense RNA mechanisms include: transcriptional interference, chromatin modification, RNA masking, dsRNA pairing, and RNA interference
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to ZNF429 (ENSG00000268081).